Table_1_Mesenchymal Stem Cells Shift Mitochondrial Dynamics and Enhance Oxidative Phosphorylation in Recipient Cells.DOCX
收藏frontiersin.figshare.com2023-06-02 更新2025-03-22 收录
下载链接:
https://frontiersin.figshare.com/articles/dataset/Table_1_Mesenchymal_Stem_Cells_Shift_Mitochondrial_Dynamics_and_Enhance_Oxidative_Phosphorylation_in_Recipient_Cells_DOCX/7331489/1
下载链接
链接失效反馈官方服务:
资源简介:
Mesenchymal stem cells (MSCs) are the most commonly used cells in tissue engineering and regenerative medicine. MSCs can promote host tissue repair through several different mechanisms including donor cell engraftment, release of cell signaling factors, and the transfer of healthy organelles to the host. In the present study, we examine the specific impacts of MSCs on mitochondrial morphology and function in host tissues. Employing in vitro cell culture of inherited mitochondrial disease and an in vivo animal experimental model of low-grade inflammation (high fat feeding), we show human-derived MSCs to alter mitochondrial function. MSC co-culture with skin fibroblasts from mitochondrial disease patients rescued aberrant mitochondrial morphology from a fission state to a more fused appearance indicating an effect of MSC co-culture on host cell mitochondrial network formation. In vivo experiments confirmed mitochondrial abundance and mitochondrial oxygen consumption rates were elevated in host tissues following MSC treatment. Furthermore, microarray profiling identified 226 genes with differential expression in the liver of animals treated with MSC, with cellular signaling, and actin cytoskeleton regulation as key upregulated processes. Collectively, our data indicate that MSC therapy rescues impaired mitochondrial morphology, enhances host metabolic capacity, and induces widespread host gene shifting. These results highlight the potential of MSCs to modulate mitochondria in both inherited and pathological disease states.
间充质干细胞(MSCs)是组织工程和再生医学中最常用的细胞。MSCs能够通过多种机制促进宿主组织修复,包括供体细胞定植、细胞信号因子的释放以及健康细胞器的转移至宿主。在本研究中,我们探讨了MSCs对宿主组织中线粒体形态和功能的特异性影响。通过采用遗传性线粒体疾病体外细胞培养和低级炎症(高脂肪饮食)的体内动物实验模型,我们发现人源MSCs能够改变线粒体功能。与线粒体疾病患者皮肤成纤维细胞的共培养,MSCs能够将异常线粒体形态从分裂状态挽救为更为融合的形态,这表明MSCs共培养对宿主细胞线粒体网络形成具有影响。体内实验证实,MSCs治疗后宿主组织中的线粒体数量和线粒体氧气消耗速率均有所升高。此外,基因芯片分析鉴定出226个在MSCs治疗的动物肝脏中差异表达的基因,其中细胞信号传导和肌动蛋白细胞骨架调控作为关键的上调过程。综上所述,我们的数据表明MSCs疗法能够挽救受损的线粒体形态,增强宿主代谢能力,并诱导宿主基因的广泛转移。这些结果突出了MSCs在遗传性和病理性疾病状态下调节线粒体的潜力。
提供机构:
Frontiers



